These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. McNeil JJ; Woods RL; Nelson MR; Murray AM; Reid CM; Kirpach B; Storey E; Shah RC; Wolfe RS; Tonkin AM; Newman AB; Williamson JD; Lockery JE; Margolis KL; Ernst ME; Abhayaratna WP; Stocks N; Fitzgerald SM; Trevaks RE; Orchard SG; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Grimm RH; J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1586-1593. PubMed ID: 28329340 [TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial. Eisen DP; Leder K; Woods RL; Lockery JE; McGuinness SL; Wolfe R; Pilcher D; Moore EM; Shastry A; Nelson MR; Reid CM; McNeil JJ; McBryde ES Lancet Respir Med; 2021 Feb; 9(2):186-195. PubMed ID: 32950072 [TBL] [Abstract][Full Text] [Related]
6. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. ASPREE Investigator Group Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028 [TBL] [Abstract][Full Text] [Related]
7. Exercise and fall prevention self-management to reduce mobility-related disability and falls after fall-related lower limb fracture in older people: protocol for the RESTORE (Recovery Exercises and STepping On afteR fracturE) randomised controlled trial. Sherrington C; Fairhall N; Kirkham C; Clemson L; Howard K; Vogler C; Close JC; Moseley AM; Cameron ID; Mak J; Sonnabend D; Lord SR BMC Geriatr; 2016 Feb; 16():34. PubMed ID: 26838998 [TBL] [Abstract][Full Text] [Related]
8. Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial. Robman LD; Wolfe R; Woods RL; Thao LTP; Makeyeva GA; Hodgson LAB; Lepham YA; Jachno K; Phung J; Maguire E; Luong H; Trevaks RE; Ward SA; Fitzgerald SM; Orchard SG; Lacaze P; Storey E; Abhayaratna WP; Nelson MR; Guymer RH; McNeil JJ JAMA Ophthalmol; 2024 Jul; 142(7):627-635. PubMed ID: 38780931 [TBL] [Abstract][Full Text] [Related]
9. Association of Plasma High-Density Lipoprotein Cholesterol Level With Risk of Fractures in Healthy Older Adults. Hussain SM; Ebeling PR; Barker AL; Beilin LJ; Tonkin AM; McNeil JJ JAMA Cardiol; 2023 Mar; 8(3):268-272. PubMed ID: 36652261 [TBL] [Abstract][Full Text] [Related]
10. Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial. Khaw KT; Stewart AW; Waayer D; Lawes CMM; Toop L; Camargo CA; Scragg R Lancet Diabetes Endocrinol; 2017 Jun; 5(6):438-447. PubMed ID: 28461159 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782 [TBL] [Abstract][Full Text] [Related]
12. Aspirin does not reduce fracture and fall risk in healthy older people. Drug Ther Bull; 2023 Jun; 61(6):85. PubMed ID: 37169520 [No Abstract] [Full Text] [Related]
13. ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly. Ward SA; Raniga P; Ferris NJ; Woods RL; Storey E; Bailey MJ; Brodtmann A; Yates PA; Donnan GA; Trevaks RE; Wolfe R; Egan GF; McNeil JJ; Int J Stroke; 2017 Jan; 12(1):108-113. PubMed ID: 27634976 [TBL] [Abstract][Full Text] [Related]
14. Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial. Berk M; Woods RL; Nelson MR; Shah RC; Reid CM; Storey E; Fitzgerald S; Lockery JE; Wolfe R; Mohebbi M; Dodd S; Murray AM; Stocks N; Fitzgerald PB; Mazza C; Agustini B; McNeil JJ JAMA Psychiatry; 2020 Oct; 77(10):1012-1020. PubMed ID: 32492080 [TBL] [Abstract][Full Text] [Related]
15. Population-based interventions for preventing falls and fall-related injuries in older people. Lewis SR; McGarrigle L; Pritchard MW; Bosco A; Yang Y; Gluchowski A; Sremanakova J; Boulton ER; Gittins M; Spinks A; Rapp K; MacIntyre DE; McClure RJ; Todd C Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013789. PubMed ID: 38180112 [TBL] [Abstract][Full Text] [Related]
16. Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial. Lowthian JA; Britt CJ; Rance G; Lin FR; Woods RL; Wolfe R; Nelson MR; Dillon HA; Ward S; Reid CM; Lockery JE; Nguyen TT; McNeil JJ; Storey E; Contemp Clin Trials; 2016 Jan; 46():60-66. PubMed ID: 26611434 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial. Clark DPQ; Zhou Z; Hussain SM; Tran C; Britt C; Storey E; Lowthian JA; Shah RC; Dillon H; Wolfe R; Woods RL; Rance G; McNeil JJ JAMA Netw Open; 2024 Jul; 7(7):e2424373. PubMed ID: 39052288 [TBL] [Abstract][Full Text] [Related]
19. An initial loading-dose vitamin D versus placebo after hip fracture surgery: randomized trial. Mak JC; Mason RS; Klein L; Cameron ID BMC Musculoskelet Disord; 2016 Aug; 17():336. PubMed ID: 27515154 [TBL] [Abstract][Full Text] [Related]
20. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS; Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]